1. Metabolic Alterations as a Signpost to Early Pancreatic Cancer
Natalia Khalaf 
Gastroenterology 
Volume 156, Issue 6, Pages (May 2019)
DOI: /j.gastro
Copyright © Terms and Conditions

2. Figure 1
Earlier detection of pancreatic cancer through enhanced risk assessment and targeted evaluation. In the general population (A), risk prediction models identify individuals at elevated risk for pancreatic cancer (B). The at-risk population is enriched for people with early-stage pancreatic cancer using circulating markers (C) to identify those for targeted imaging to visualize the pancreatic tumor (D). Detection of the tumor is followed by tissue diagnosis and earlier therapeutic intervention with a greater likelihood for cure (E). Chol, cholesterol; CTCs, circulating tumor cells; ctDNA, circulating tumor DNA; miRNA, microRNA; T3cDM, type IIIc diabetes mellitus.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © Terms and Conditions